Dr. Francesco Guerrera

Dr. Francesco Guerrera

Medico Chirurgo Specialista in Chirurgia Toracica

ESPERIENZA PROFESSIONALE

Chirurgo Toracico - Consulente
AOU Città della Salute e della Scienza di Torino - S.C. Chirurgia Toracica U, Torino (Italia).

Medico consulente per la Prevenzione delle Neoplasie dell’Apparato Respiratorio
Associazione per la Prevenzione e la Cura dei Tumori in Piemonte – Onlus, Torino (Italia).

Dottorando di Ricerca con Autorizzazione allo Svolgimento dell'Attività Clinica e Assistenziale
A.O.U. Città della Salute e della Scienza di Torino - S.C. Chirurgia Toracica U, Torino (Italia).

Praticien Attaché Spécialiste
Les Hôpitaux Universitaires de Strasbourg - Service de Chirurgie Thoracique et Transplantation Pulmonaire, Strasburgo (Francia).

Medico di Continuità Assistenziale
A.S.L. TO4 - Azienda Sanitaria Locale di Ciriè, Chivasso, Ivrea, Chivasso (Italia).

Specializzando in Chirurgia Toracica
A.O.U. Città della Salute e della Scienza di Torino - S.C. Chirurgia Toracica U, Torino (Italia).

Visiting Doctor
Memorial Sloan Kettering Cancer Center (MSKCC), Department of Surgery - Services of Thoracic Surgery, New York City (Stati Uniti d'America).


ISTRUZIONE E FORMAZIONE

Ph.D Student
Politecnico di Torino e Università degli Studi di Torino (Italia).

Diplôme Inter-universitaire de Chirurgie Robotique
Université de Lorraine, Nancy (Francia)

Specializzazione in Chirurgia Toracica

Università degli Studi di Torino (Italia)

Abilitazione all'esercizio della professione di Medico Chirurgo 

Ordine dei Medici Chirurghi ed Odontoiatri della Provincia di Torino (Italia)

Laurea Magistrale in Medicina e Chirurgia

Università degli Studi di Torino (Italia)


Corsi

IN QUALITA' DI DOCENTE

Resezioni polmonari maggiori in Toracoscopia Video-Assistita (VATS), Maggio 2019, Torino, Italia


Ecografia Polmonare, Aprile 2012, Torino, Italia


CONFERENZE

PARTECIPAZIONE IN QUALITA' DI MODERATORE

  • 27th European Conference on General Thoracic Surgery, Giugno 2019. Dublin, Irlanda
  • 26th European Conference on General Thoracic Surgery, Maggio 2018. Ljubljana , Slovenia
  • 25th European Conference on General Thoracic Surgery, Maggio 2017. Innsbruck, Austria

PARTECIPAZIONE IN QUALITA' DI RELATORE

  • Chirurgia Insieme - Convegno Congiunto delle Società Specialistiche Chirurgiche Italiane, Giugno 2019. Genova, Italia
  • 27th European Conference on General Thoracic Surgery, Giugno 2019. Dublin, Irlanda
  • Lung Young multi regionale: aggiornamenti nel trattamento del carcinoma del polmone, Aprile 2019. Camogli, Italia
  • The SPIGC XXX Congress, Marzo 2019. Genova, Italia
  • The SICT 36th Congress, Ottobre 2018. Mantova, Italia
  • The IASLC 19th World Conference on Lung Cancer, Settembre 2018. Toronto, Canada
  • The ERS International Congress 2018, Settembre 2018, Paris, France
  • The SIET 19th Congress, Settembre 2017. Lecce, Italia
  • The IASLC 18th World Conference on Lung Cancer, Ottobre 2017. Yokohama, Japan
  • 25th European Conference on General Thoracic Surgery, Giugno 2017. Innsbruck, Austria
  • 24th European Conference on General Thoracic Surgery, Maggio 2016, Naples, Italia
  • Perdite Aeree in Chirurgia Toracica: un problema clinico ed econimico, Giugno 2015, Torino, Italia
  • 22nd European Conference on General Thoracic Surgery, Maggio 2014. Copenhagen, Danimarca
  • The SICT 33rd Congress, Giugno 2012. Pisa, Italia

ATTIVITÀ DI REVISIONE

RIVISTE SCIENTIFICHE INTERNAZIONALI

  • Theranostics
  • Oncologist
  • BMC cancer
  • Therapeutic Advances in Medical Oncology
  • Annals of Thoracic Surgery
  • European journal of cardio-thoracic surgery
  • Expert Review of Respiratory Medicine
  • Future Oncology
  • Interactive CardioVascular and Thoracic Surgery
  • Journal of Thoracic Disease
  • Biopreservation and Biobanking
  • Translational Cancer Research

Riconoscimenti e Premi

  • Robert Ginsberg Lectureship Award (Surgery) - World Conference on Lung Cancer (2017)
  • YOUNG INVESTIGATORS Scholarship AWARD - International Association for the Study of Lung Cancer (IASLC) (2017)
  • Vincitore di Borsa di Studio "SVILUPPO DI UNA TECNICA DI IMAGING INTRAOPERATORIA PER LA VISUALIZZAZIONE DI NODULI POLMONARI NELLE PROCEDURE CHIRURGICHE MINI_INVASIVE VIDEO-ASSISTITE E ROBOT-ASSISTITE" - Compagnia di San Paolo (2017)
  • YOUNG INVESTIGATORS AWARD - European Society of Thoracic Surgeons (ESTS) (2016)

Libri e Monografie

  1. Aseni Paolo. “Operative Techniques and Recent Advances in Acute Care and Emergency Surgery”. In: Springer, 2018. Capitoli: Pleural, Lung and Airways Injuries.
  2. de Herde Wouter Colao Annamaria Faggiano Antongiulio. “Neuroendocrine Tumors in Real Life”. In: Springer, 2018. Capitoli: Tumor Staging: Bronchi.
  3. Oliaro Alberto Loizzi Michele. “Malattie dell’apparato respiratorio”. In:Minerva Medica, 2015. Capitoli: Anatomia; Anatomia Funzionale; Sindrome Dello Stretto Toracico Superiore; Malattie Vascolari Polmonari; Resezioni Polmonari

Dettagli del profilo

  • Specialità Chirurgia toracica
  • Chirurgia polmonare
  • Tipologia di attività Interventi chirurgici
  • Visite specialistiche
  • Chirurgia guidata dalla fluorescenza
  • Simpatectomia
  • Ricerca scientifica
  • Email fguerrera@chirurgiatoracicarobotica.com
  • Mobile +39 351 506 9500

Competenze Personali

Lingua madre Italiano

Altre Lingue Inglese - Francese

Altre Competenze

  • Awake e Non-intubated surgery, nell'ambito della Chirurgia Toracica delle Interstiziopatie polmonari e dell'Enfisema Polmonare
  • Chirurgia Toracica Robotica, presso AOU Città della Salute e della Scienza di Torino e NHC Les Hôpitaux Universitaires de Strasbourg
  • Prelievo e trapianto polmonare, presso NHC Les Hôpitaux Universitaires de Strasbourg
  • Vacuum Assisted Closure Therapy, nell'ambito della Chirurgia Toracica
  • Osteosintesi costale (Sistemi StraCos™ e StraTos)
  • Ecografia Toracica

Esperienza Chirurgica

  • Esperienza nelle tecniche chirurgiche resezione polmonare per via toracoscopica con tecnica ”AWAKE”
  • Esperienza nelle tecniche chirurgiche di toracoscopia video-assistita
  • Esperienza nelle tecniche chirurgiche di toracoscopia robot-assistita

Certificazioni Internazionali

  • daVinci Xi System for Surgeons, Intuitive Surgical, Gennaio 2018
  • Formazione Specifica alla Salute e Sicurezza per i Lavoratori, Università degli Studi di Torino e A.O.U. Città della Salute e della Scienza di Torino, Maggio 2017
  • Diplôme Inter-universitaire de Chirurgie Robotique, Université de Lorraine, Nancy (Francia), Novembre 2016
  • Good Clinical Practice, Novartis, Novembre 2016

Appartenenza a gruppi / Associazioni

SOCIETA' SCIENTIFICHE

COMITATI

  • Comitato per le Pubblicazioni, IASLC , International Association for the Study of Lung Cancer

MEMBRO

  • ESTS, European Society of Thoracic Surgeons
  • IASLC, International Association for the Study of Lung Cancer
  • EORTC, European Organisation for Research and Treatment of Cancer
  • ITMIG, International Thymic Malignancies Interest Group
  • SMIT, Society for Medical Innovation and Technology
  • SICT, Società Italiana di Chirurgia Toracica
  • SPIGC, Società Polispecialistica Italiana dei Giovani Chirurghi

PUBBLICAZIONI

IN RIVISTE SCIENTIFICHE INTERNAZIONALI

CITAZIONI: 536; HIRSCH INDEX: 13 (SCOPUS–ELSEVIER)

1) L. Losappio et al. “Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study”. In: BMC Pulm Med 19.1 (June 2019), p. 107.

2) [F. Tabbo et al. “SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer”. In: Ann Transl Med 7.9 (May 2019), p. 190.

3) P. Capdevielle et al. “Right chylothorax complicating videothoracoscopic management of recurrent pneumothorax””. In: Chirurgia (Turin) 32.2 (Apr. 2019), pp. 102–103.

4) [4] M. Cattoni et al. “Sublobar resection in the treatment of peripheral typical carcinoid tumors of the lung”. In: Ann. Thorac. Surg. (Mar. 2019).

5) F. Guerrera et al. “Risk of recurrence in stage I adenocarcinoma of the lung: a multi-institutional study on synergism between type of surgery and type of nodal staging”. In: J Thorac Dis 11.2 (Feb. 2019), pp. 564–572.

6) P. Bertoglio et al. “Chest drain and thoracotomy for chest trauma”. In: J Thorac Dis 11. Suppl 2 (Feb. 2019), S186–S191.

7) P. L. Filosso et al. “Surgical management of chronic diaphragmatic hernias”. In: J Thorac Dis 11. Suppl 2 (Feb. 2019), S177–S185.

8) [8] M. Cattoni et al. “Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long- Term Outcomes After R0 Resection”. In: World J Surg (Feb. 2019).

9) S.Bongiolatti e tal. “Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database”. In: Surg Endosc (Jan. 2019).

10) L. Bertolaccini et al. “Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry”. In: Eur J Surg Oncol (Jan. 2019).

11) E. Ruffini et al. “Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours”. In: Eur J Cardiothorac Surg (Jan. 2019).

12) P.SolidoroandF.Guerrera.“Theimportanceofadiagnosticpathwayinthediagnosisofhaemoptysis”. In: Adv Respir Med (Dec. 2018).

13) F.Guerreraetal.“Changingparadigmsofnon-smallcelllungcancertreatment”.In: JThoracDis 10.Suppl 33 (Nov. 2018).

14) S. Renaud et al. “Prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer”. In: Eur J Cardiothorac Surg (Dec. 2018).

15) E. Pompeo et al. “Nonintubated surgical biopsy of undetermined interstitial lung disease: a multicentre outcome analysis”. In: Interact Cardiovasc Thorac Surg(Dec. 2018).

16) P.L. Filosso et al. “The European Society of Thoracic Surgeons (ESTS) lung neuroendocrine tumors (NETs) database”. In: J Thorac Dis 10.Suppl 29 (Oct. 2018).

17) E. Ruffini et al. “The European Society of Thoracic Surgeons (ESTS) thymic database”. In: J Thorac Dis 10.Suppl 29 (Oct. 2018), S3516–S3520.

18) S. Renaud et al. “KRAS-specific Amino Acid Substitutions are Associated with Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer”. In: Clin Lung Cancer (Aug. 2018).

19) C. Cao et al. “European questionnaire on the clinical use of video-assisted thoracoscopic surgery”. In: Interact Cardiovasc Thorac Surg (Mar. 2018).

20) A. Streit et al. “Pseudochylothorax: An unusual mode of revelation of pleural metastasis from solid

tumor”. In: Tumori (Aug. 2018).

21) P. L. Filosso et al. “Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids”. In: Eur J Cardiothorac Surg (July 2018)

22) S. Renaud et al. “Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations”. In: Ann. Surg. (May 2018).

23) P. Solli et al. “2016 Annual report from the Italian VATS Group”. In:Future Oncol 14.6s (Mar. 2018).

24) D. Divisi et al. “National adoption of video-assisted thoracoscopic surgery (VATS) lobectomy: the Italian VATS register evaluation”. In: J Thorac Dis 10.1 (Jan. 2018).

25) A. Gonfiotti et al. “Safety of lymphadenectomy during video-assisted thoracic surgery lobectomy: analysis from a national database”. In: Eur J Cardiothorac Surg (Mar. 2018).

26) E. Ruffini et al. “Optimal surgical approach to thymic malignancies: New trends challenging old dogmas”. In: Lung Cancer 118 (Apr. 2018).

27) P. L. Filosso et al. “Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice”. In: J Thorac Dis (Jan. 2018).

28) F. Guerrera et al. “Application of the coaxial smart drain in patients with a large air leak following anatomic lung resection: a prospective multicenter phase II analysis of efficacy and safety”. In: J Vis Surg (Feb. 2018).

29) M. Boita et al. “Basophil Membrane Expression of Epithelial Cytokine Receptors in Patients with Severe Asthma”. In: Int. Arch. Allergy Immunol. (Feb. 2018).

30) F. Tabbo et al. “Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma”. In: Hum. Pathol. (Jan. 2018).

31) S. Renaud et al. “Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma”. In: Ann. Surg. Oncol. (Jan. 2018).

32) P. L. Filosso et al. “Locally advanced non-small cell lung cancer treatment: another step forward”. In:J Thorac Dis 9.12 (Dec. 2017), pp. 4908–4911.

33) A. Gonfiotti et al. “Thoracoscopic lobectomy for locally advanced-stage non-small cell lung cancer is afeasible and safe approach: analysis from multi-institutional national database”. In: J Vis Surg 3 (Nov.2017), p. 160.

34) P. Bertoglio, S. Renaud, and F. Guerrera. “Unless I see, I will not believe”. In: J Thorac Dis 9.9 (Sept.2017), pp. 2835–2838.

35) P. L. Filosso et al. “Neuroendocrine tumors of the thymus”. In: J Thorac Dis 9.Suppl 15 (Nov. 2017),S1484–S1490.

36) P. L. Filosso et al. “The utility of blood neuroendocrine gene transcript measurement in the diagnosisof bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection anddisease progression”. In: Eur J Cardiothorac Surg (Nov. 2017).

37) H. Decaluwe et al. “Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I nonsmall-cell lung cancer”. In: Eur J Cardiothorac Surg (Sept. 2017).

38) M. Cattoni et al. “Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size”. In: J. Thorac. Cardiovasc. Surg. (Jan. 2018),

39) A. Bertani et al. “Nodal management and upstaging of disease: initial results from the Italian VATS Lobectomy Registry”. In: J Thorac Dis (July 2017).

40) F. Guerrera et al. “How to design a randomized clinical trial: tips and tricks for conduct a successful study in thoracic disease domain”. In: J Thorac Dis (Aug. 2017), pp. 2692–2696.

41) D. Divisi et al. “Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients”. In: J Thorac Dis (Aug. 2017),

42) F. Guerrera et al. “Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer”. In: Ann. Thorac. Surg. 104.4 (Oct. 2017), pp. 1194–1199.

43) P. L. Filosso et al. “Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database”. In: Eur J Cardiothorac Surg 52.2 (Aug. 2017), pp. 339–345.

44) F. Guerrera et al. “Does perioperative chemotherapy improve survival in patients with resectable lung metastases of colorectal cancer?” In: Interact Cardiovasc Thorac Surg 24.5 (May 2017), pp. 789–791.

45) B. Moser et al. “Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project”. In: Eur J Cardiothorac Surg 52.2 (Aug. 2017), pp. 346–355.

46) A. Nottegar et al. “Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis”. In: Exp. Mol. Pathol. 102.2 (Apr. 2017), pp. 276–279.

47) P. L. Filosso et al. “Primary lung tumors invading the chest wall”. In: J Thorac Dis 8.Suppl 11 (Nov. 2016), S855–S862.

48) S. Renaud et al. “KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer”. In: Oncotarget 8.2 (Jan. 2017), pp. 2514–2524.

49) P. L. Filosso et al. “Management of Chest Drains After Thoracic Resections”. In: Thorac Surg Clin 27.1 (Feb. 2017), pp. 7–11.

50) P. L. Filosso et al. “Errors and Complications in Chest Tube Placement”. In: Thorac Surg Clin

27.1 (Feb. 2017), pp. 57–67.

51) A. Sandri et al. “Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma”. In: J Thorac Dis 8.8 (Aug. 2016), pp. 2121–2127.

52) P. L. Filosso et al. “Multimodality therapy for locally-advanced thymic epithelial tumors: where are we now?” In: J Thorac Dis 8.7 (July 2016), pp. 1428–1430.

53) P. L. Filosso et al. “When size matters: changing opinion in the management of pleural space-the rise of small-bore pleural catheters”. In: J Thorac Dis 8.7 (July 2016), E503–510.

54) F. Guerrera et al. “Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery”. In: J Thorac Dis 8.7 (July 2016), pp. 1764–1771.

55) P. L. Filosso et al. “Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons”. In: Future Oncol 12.17 (Sept. 2016), pp. 1985–1999.

56) P. L. Filosso et al. “Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group”. In: Eur J Cardiothorac Surg 50.4 (Oct. 2016), pp. 766–771.

57) P. L. Filosso et al. “Efficacy and safety of human fibrinogen-thrombin patch (Tachosil(®)) in the management of diffuse bleeding after chest wall and spinal surgical resection for aggressive thoracic neoplasms”. In: J Thorac Dis 8.1 (Jan. 2016), E152–156.

58) A. R. Filippi et al. “Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer”. In: Clin Oncol (R Coll Radiol) 28.8 (Aug. 2016), pp. 505–512.

59) F. Guerrera et al. “The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank”. In: PLoS ONE 11.1 (2016), e0145100.

60) F. Guerrera et al. “Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas”. In: Eur J Cardiothorac Surg 51.4 (Apr. 2017), pp. 680–688.

61) P. L. Filosso et al. “Digital versus traditional air leak evaluation after elective pulmonary resection: a prospective and comparative mono-institutional study”. In: J Thorac Dis 7.10 (Oct. 2015), pp. 1719– 1724.

62) P. L. Filosso et al. “Multidisciplinary management of advanced lung neuroendocrine tumors”. In:

J Thorac Dis 7. Suppl 2 (Apr. 2015), S163–171.

63) P. L. Filosso et al. “Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients”. In: Lung Cancer 88.3 (June 2015), pp. 338–343.

64) P. L. Filosso et al. “Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine

Tumours Working Group”. In: Eur J Cardiothorac Surg 48.3 (Sept. 2015), pp. 441–447.

65) E. Ruffini, F. Guerrera, and P. L. Filosso. “Reply to Hamaji”. In: Eur J Cardiothorac Surg 48.2 (Aug. 2015), pp. 340–341.

66) E. Ruffini et al. “Extended transcervical thymectomy with partial upper sternotomy: results in nonthymomatous patients with myasthenia gravis”. In: Eur J Cardiothorac Surg 48.3 (Sept. 2015), pp. 448–454.

67) P. L. Filosso et al. “Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†”. In: Eur J Cardiothorac Surg 48.1 (July 2015), pp. 55–64.

68) F. Guerrera et al. “Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†”. In: Eur J Cardiothorac Surg 47.6 (June 2015), pp. 1037–1043.

69) P. L. Filosso et al. “Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases”. In: J. Thorac. Cardiovasc. Surg. 149.1 (Jan. 2015), pp. 103–109.

70) F. Guerrera et al. “Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients”. In: Eur J Cardiothorac Surg 48.1 (July 2015), pp. 48–54.

71) P. O. Lausi et al. “Thymic neuroendocrine tumors”. In: Thorac Surg Clin 24.3 (Aug. 2014), pp. 327–332.

72) E. Ruffini et al. “Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database”. In: J Thorac Oncol 9.4 (Apr. 2014), pp. 541–548.

73) P. L. Filosso et al. “Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients”. In: Eur J Cardiothorac Surg 45.6 (June 2014), pp. 1020–1027.

74) P. L. Filosso et al. “Outcome and prognostic factors in bronchial carcinoids: a single-center experience”. In: J Thorac Oncol 8.10 (Oct. 2013), pp. 1282–1288.

75) P. L. Filosso et al. “Outcome of surgically resected thymic carcinoma: a multicenter experience”. In: Lung Cancer 83.2 (Feb. 2014), pp. 205–210.

76) N. Daddi et al. “Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids”. In: Eur J Cardiothorac Surg 45.4 (Apr. 2014), pp. 677–686.

77) P. L. Filosso et al. “Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience”. In: Eur J Cardiothorac Surg 45.3 (Mar. 2014), pp. 521–526.

PRENOTA ADESSO O RICHIEDI INFORMAZIONI

DR. FRANCESCO GUERRERA - Chirurgo toracico